Pigmentation Disorders Treatment: The Global Market is Set to Reach $9.65 Billion by 2026 - ResearchAndMarkets.com

September 18, 2018

DUBLIN--(BUSINESS WIRE)--Sep 18, 2018--The “Global Pigmentation Disorders Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026” report has been added to ResearchAndMarkets.com’s offering.

The global pigmentation disorders treatment market was valued at US$ 5311.5 Mn in 2017, and is expected to reach US$ 9649.9 Mn by 2026, expanding at a CAGR of 6.9% from 2018 to 2026.

Microdermabrasion is gaining prominence due to its growing popularity over the counter product (OTC) for the treatment of skin defects such as dark spots and wrinkles.

In the present scenario, melasma is dominating the disease type segment due to its high incidence rate in the Caucasian population, which comprises 55 to 60% of the world population. Hormonal changes, pregnancy and birth control pills are responsible for the occurrence of melasma in 90% women throughout the globe.

Vitiligo will be highlighting growth at a rapid pace due to its high prevalence in Negroid and Mongoloid population. Technological advancement in photo and laser therapy has been able to treat vitiligo up to a certain extent.

Key Highlights

Rising incidence of albinism and vitiligo in the negroid and aboriginal population Availability of numerous combinations of topical creams to treat face hyperpigmentation due to acne, pox, accidents etc., in the Caucasian population Supportive regulatory environment will contribute towards the growth of pigmentation disorders market

Key Topics Covered

Chapter 1. Preface

Chapter 2. Executive Summary

Chapter 3. Pigmentation Disorders Treatment Market: Dynamics and Future Outlook

Chapter 4. Global Pigmentation Disorders Treatment Market, by Treatment Type

Chapter 5. Global Pigmentation Disorders Treatment Market, by Disease Type

Chapter 6. Global Pigmentation Disorders Treatment Market, by Geography

Chapter 7. Company Profiles

Allergan Plc Bayer AG Galderma S.A. EpiPharm AG Pierre Fabre Laboratories La Roche-Posay Laboratoire Pharmaceutique Obagi Cosmeceuticals LLC RXi Pharmaceuticals Corporation SkinCeuticals, Inc. Vivier Pharma, Inc.

For more information about this report visit https://www.researchandmarkets.com/research/84g7ng/pigmentation?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180918005523/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Pigments



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/18/2018 07:55 AM/DISC: 09/18/2018 07:55 AM


Update hourly